NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/135930 |
Resumo: | Funding Information: This study was supported by Roche Diagnostics. The authors had full control of the content and made the final decision on all aspects of this article. Publisher Copyright: © 2021 Sociedade Portuguesa de Cardiologia |
id |
RCAP_0e926f8d2acc70af31201bd1bde38b8b |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/135930 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primáriosNT-proBNP for heart failure diagnosis in Primary CareCosts or savings? A budget impact studyCustos ou ganhos? Estudo de impacto orçamentalBiomarkersChronic heart failureDiagnosisNatriuretic peptides NT-proBNPPrimary health careCardiology and Cardiovascular MedicineSDG 3 - Good Health and Well-beingFunding Information: This study was supported by Roche Diagnostics. The authors had full control of the content and made the final decision on all aspects of this article. Publisher Copyright: © 2021 Sociedade Portuguesa de CardiologiaIntroduction and objectives: Chronic heart failure (CHF) is a growing public health concern and diagnosis can be challenging, particularly in primary care. This study aims to estimate the budgetary impact of introducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) for CHF diagnosis in a primary care setting from the perspective of the Portuguese health system. Methods: A budget impact analysis was conducted over one-year from the patients’ first presentation. The standard of care (SoC) was compared to NT-proBNP at the point-of-care (PoC) or laboratory (Lab). A decision tree model was used to estimate the downstream costs associated with each of the three pathways. Results: An estimated 81 012 patients were expected to present to primary care with new onset CHF symptoms. The use of NT-proBNP as a primary diagnostic tool is estimated to generate annualized savings of EUR 935 657 and EUR 2 982 443 in the Lab and PoC setting, respectively. Estimated cost savings were due to the need for fewer medical visits, hospitalizations and echocardiograms (ECHO). The Lab and PoC settings led to similar reductions in hospitalizations (14.4%) and ECHO (27%), but the reduction in medical visits was higher in the PoC setting (38% compared to 2.5%), resulting in higher savings compared to Lab. Conclusions: Using NT-proBNP for CHF diagnosis in primary care could result in considerable costs savings for the public health system in Portugal. This evidence might support health policy makers to reconsider the resource management and define a new strategy to mitigate the impact of CHF.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNFonseca, CândidaBettencourt, PauloBrito, DulceFebra, HelenaPereira, ÁlvaroGenovez, VictóriaLopes, Nelson2022-04-05T22:57:59Z2022-032022-03-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11application/pdfhttp://hdl.handle.net/10362/135930por0870-2551PURE: 42980761https://doi.org/10.1016/j.repc.2021.03.009info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:14:14Zoai:run.unl.pt:10362/135930Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:48:33.477437Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários NT-proBNP for heart failure diagnosis in Primary CareCosts or savings? A budget impact study Custos ou ganhos? Estudo de impacto orçamental |
title |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
spellingShingle |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários Fonseca, Cândida Biomarkers Chronic heart failure Diagnosis Natriuretic peptides NT-proBNP Primary health care Cardiology and Cardiovascular Medicine SDG 3 - Good Health and Well-being |
title_short |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
title_full |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
title_fullStr |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
title_full_unstemmed |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
title_sort |
NT-proBNP no diagnóstico de insuficiência cardíaca nos cuidados de saúde primários |
author |
Fonseca, Cândida |
author_facet |
Fonseca, Cândida Bettencourt, Paulo Brito, Dulce Febra, Helena Pereira, Álvaro Genovez, Victória Lopes, Nelson |
author_role |
author |
author2 |
Bettencourt, Paulo Brito, Dulce Febra, Helena Pereira, Álvaro Genovez, Victória Lopes, Nelson |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Fonseca, Cândida Bettencourt, Paulo Brito, Dulce Febra, Helena Pereira, Álvaro Genovez, Victória Lopes, Nelson |
dc.subject.por.fl_str_mv |
Biomarkers Chronic heart failure Diagnosis Natriuretic peptides NT-proBNP Primary health care Cardiology and Cardiovascular Medicine SDG 3 - Good Health and Well-being |
topic |
Biomarkers Chronic heart failure Diagnosis Natriuretic peptides NT-proBNP Primary health care Cardiology and Cardiovascular Medicine SDG 3 - Good Health and Well-being |
description |
Funding Information: This study was supported by Roche Diagnostics. The authors had full control of the content and made the final decision on all aspects of this article. Publisher Copyright: © 2021 Sociedade Portuguesa de Cardiologia |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-05T22:57:59Z 2022-03 2022-03-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/135930 |
url |
http://hdl.handle.net/10362/135930 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
0870-2551 PURE: 42980761 https://doi.org/10.1016/j.repc.2021.03.009 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
11 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138086890766336 |